BridgeBio Pharma BBIO
NASDAQ BBIO
$67.25 +0.34 (+0.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

BridgeBio Pharma (BBIO) Cost of Revenue (2021 - 2026)

Updated

BridgeBio Pharma's Cost of Revenue was $15.05 million in Q2 2026, up 311.9% from $3.65 million a year earlier and up 51.4% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Cost of Revenue (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, BridgeBio Pharma's Cost of Revenue was $39.66 million through Jun 30, 2026, up 341.9% year-over-year; for FY2025, it was $20.96 million, up 440.5% from FY2024.

  • Cost of Revenue shows a four-year compound annual growth rate of 61.1% (FY2021 to FY2025).
  • In earlier years, Cost of Revenue was $3.88 million in FY2024 (+58.5%), $2.45 million in FY2023 (-28.8%), $3.43 million in FY2022 (+10.3%) and $3.11 million in FY2021.
  • The Q2 2026 figure marks the highest quarterly Cost of Revenue in data going back to Q2 2021.
  • Compared with a year earlier, Cost of Revenue has increased for seven straight quarters, with growth averaging 372.0% over the last eight quarters.
  • The best year-over-year quarter for Cost of Revenue over five years was Q3 2025 (growth of 997.5%); the worst was Q4 2022 (a decline of 58.3%).
  • Per Business Quant data, BBIO's Cost of Revenue in the three quarters before Q2 2026 was $9.94 million (Q1 2026), $8.11 million (Q4 2025) and $6.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 BridgeBio Pharma 13.13 Bn 10.25 Bn 228.63 Mn 15.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.05 Mn
Mar 31, 2026 9.94 Mn
Dec 31, 2025 8.11 Mn
Sep 30, 2025 6.56 Mn
Jun 30, 2025 3.65 Mn
Mar 31, 2025 2.64 Mn
Dec 31, 2024 2.08 Mn
Sep 30, 2024 598,000.00
Jun 30, 2024 598,000.00
Mar 31, 2024 598,000.00
Dec 31, 2023 598,000.00
Sep 30, 2023 598,000.00
Jun 30, 2023 599,000.00
Mar 31, 2023 651,000.00
Dec 31, 2022 647,000.00
Sep 30, 2022 739,000.00
Jun 30, 2022 700,000.00
Mar 31, 2022 1.35 Mn
Dec 31, 2021 1.55 Mn
Sep 30, 2021 1.45 Mn
API Access

BridgeBio Pharma Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=BBIO&period=max&api_key=YOUR_API_KEY